Research programme: human papillomavirus vaccine - TakedaAlternative Names: HPV vaccine - Takeda; Low-cost human papilloma virus vaccine - Takeda
Latest Information Update: 23 Jul 2014
At a glance
- Originator Inviragen
- Developer Takeda Pharmaceuticals USA
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Human papillomavirus infections